MICA triggering signal for NK cell tumor lysis is counteracted by HLA-G1-mediated inhibitory signal

International Journal of Cancer

Volumn 100, Issue 1, 2002, Pages 63-70

  Menier, Catherine ^a   Riteau, Béatrice ^a   Carosella, Edgardo D ^a   Rouas Freiss, Nathalie ^a  

^a Inst Univ d'Hématologie   (France)

Author keywords

HLA G1; Immunosurveillance; MICA, NK cell; Tumor

Indexed keywords

COMPLEMENTARY DNA; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA E ANTIGEN; HLA G ANTIGEN; HLA G1 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MICA; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CELL SURFACE; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXICITY; EPITHELIUM TUMOR; HUMAN; HUMAN CELL; MELANOMA; NATURAL KILLER CELL; PRIORITY JOURNAL; TUMOR GROWTH;

ANIMALS; ANTIBODIES, MONOCLONAL; BIOTINYLATION; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; IMMUNOSORBENT TECHNIQUES; KILLER CELLS, NATURAL; MELANOMA; MEMBRANE PROTEINS; MICE; NEOPLASMS; PLACENTA; PREGNANCY; RATS; SIGNAL TRANSDUCTION; TRANSFECTION; TROPHOBLASTS; TUMOR CELLS, CULTURED;

EID: 0036643849     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10460     Document Type: Article

References (72)

1. Human NK-cell receptors
2. Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C
3. Existence of both inhibitory (p58) and activitory (p50) receptors for HLA-C molecules in human natural killer cells
4. Molecular cloning of NKp46: A novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity
5. p46, a novel natural killer cell-specific surface molecule which mediates cell activation
6. Recognition of hemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells
7. Identification and molecular characterization of NKp30 a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells
8. NKp44 a triggering receptor involved in tumor cell lysis by activated human natural killer cells is a novel member of the immunoglobulin superfamily
9. Identification of NKp80 a novel triggering molecule expressed by human NK cells
10. Activation of NK Cells and T Cells by NKG2D a receptor for stress-inducible MICA
11. An activating immuno receptor complex formed by NKG2D and DAP10
12. ULBPs novel MHC Class I-related molecules bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor
13. ULBP 123: Novel MHC Class I-related molecules that bind to human cytomegalovirus glycoprotein UL16 activate NK cells
14. Conformational plasticity revealed by the co-crystal structure of NKG2D and its Class I MHC-like ligand ULBP3
15. UL16-binding proteins novel MHC Class I-related proteins bind to NKG2D and activate multiple signaling pathways in primary NK cells
16. Cell stress-regulated human major histocompatibility complex Class I gene expressed in gastrointestinal epithelium
17. Crystal structure of the MHC Class I homolog MIC-A a γδ T cell ligand
18. Complex structure of the activating immunoreceptor NKG2D and its MHC Class I-like ligand MICA
19. MIC genes: From genetics to biology
20. A second lineage of mammalian major histocompatibility complex Class I genes
21. MICA MICB genes: Can the enigma of their polymorphism be resolved?
22. Broad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB
23. Role of NKG2D in tumor cell lysis mediated by human NK cells: Cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin
24. Inhibitory MHC Class I receptors on NK cells and T cells
25. Paired inhibitory and triggering NK cell receptors for HLA Class I molecules
26. HLA-E binds to natural killer cell receptors CD94/NKG2A B and C
27. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A
28. A common inhibitory receptor for major histocompatibility complex Class I molecules on human lymphoid and myelomonocytic cells
29. A novel immunoglobulin superfamily receptor for cellular and viral MHC Class I molecules
30. Heterogeneity of HLA-G gene transcription and protein expression in malignant melanoma biopsies
31. Expression analysis of classic and non-classic HLA molecules before interferon ala-2b treatment of melanoma
32. Soluble human leukocyte antigen-G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy
33. HLA-G HLA-E: Fundamental and pathophysiological aspects
34. Tumor-specific upregulation of the nonclassical Class I HLA-G antigen expression in renal carcinoma
35. HLA-G protein upregulation in primary cutaneous lymphomas is associated with interleukin-10 expression in large cell T cell lymphomas and indolent B cell lymphomas
36. Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology human leukocyte antigen Class I loss and interleukin-10 production
37. Increased expression of human histocompatibility leucocyte antigen-G in colorectal cancer cells
38. A Class I antigen HLA-G expressed in human trophoblasts
39. Identification of a thymic epithelial cell subset sharing expression of the Class Ib HLA-G molecule with fetal trophoblasts
40. HLA-G mediated-inhibition of antigen-specific cytotoxic T lymphocytes
41. HLA-G inhibits the allogeneic proliferative response
42. A human histocompatibility leucocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells
43. Inhibitory receptors sensing HLA-G1 molecules in pregnancy: Decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49 an HLA-G1-specific receptor
44. The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules coexpressed on target cells
45. HLA-G2 -G3 and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis
46. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis
47. HLA-G expression in melanoma: A way for tumor cells to escape from immunosurveillance
48. HLA-G -E -F preworkshop: Tools and protocols for analysis of non classical Class I genes transcription and protein expression
49. Characterization of a cell line NKL derived from an aggressive human natural killer cell leukemia
50. HLA-G truncated isoforms can substitute for HLA-G1 in fetal survival
51. The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association
52. The α1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: Is HLA-G the public ligand for natural killer cell inhibitory receptors?
53. HLA-G1 coexpression boosts the HLA Class I-mediated NK lysis inhibition
54. Cellular immune recognition of HLA-G expressing choriocarcinoma cell line JEG-3
55. Differential surface expression of MICA by endothelial cells fibroblasts keratinocytes and monocytes
56. Structure function and diversity of Class I major histocompatibility complex molecules
57. Recognition of stress-induced MHC molecules by intestinal epithelial γδ T Cells
58. Costimulation of CD8αβT cells by NKG2D via engagement by MIC induced on virus-infected cells
59. Induction of IFN-γ production but not cytotoxicity by the killer cell Ig-like receptor KIR2DL4 (CD158d) in resting cells
60. Implications for immunosurveillance of altered HLA Class I phenotypes in human tumors
61. Antigen-processing machinery breakdown and tumor growth
62. Tumor escape from immune recognition
63. The host-tumor immune conflict: From immunosuppression to resistance and destruction
64. Melanoma cell expression of Fas (Apo-1/CD95) ligand: Implications for tumor escape
65. Embryo implantation and tumor metastasis: Common pathways of invasion and angiogenesis
66. Triggering receptors involved in natural killer cell-mediated cytotoxicity against choriocarcinoma cell lines
67. Identification of MICA as a new polymorphic alloantigen recognized by antibodies in sera of organ transplant recipients
68. Implication of HLA-G molecule in heart-graft acceptance
69. PERB11 (MIC): A polymorphic MHC gene is expressed in skin and single nucleotide polymorphisms are associated with psoriasis
70. MICA 5.1 allele is a susceptibility marker for psoriasis in the Korean population
71. The inflammatory infiltrate in psoriasis
72. HLA-G NK receptor are expressed in psoriatic skin: A possible pathway for regulating infiltrating T cells?